| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.21B | $1.21B | $1.16B |
| YoY Revenue Growth % | +0.5% | +4.6% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $871.2M | $900.3M | $841.3M |
| Operating Margin % | 71.8% | 74.5% | 72.8% |
| Net Income (GAAP) | $738.3M | $763.0M | $712.9M |
| EBITDA (Normalized) | $872.1M | $901.3M | $882.9M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $852.8M | $725.0M | $713.0M |
| Capital Expenditures (CapEx) | $1.0M | $1.2M | $52.0M |
| Free Cash Flow (FCF) | $851.8M | $723.9M | $661.0M |
| FCF Margin % | 70.2% | 59.9% | 57.2% |
| Return on Invested Capital (ROIC %) | 12.6% | 12.8% | 33.8% |
| Cash & Short-Term Equivalents | $369.0M | $229.5M | — |
| Total Debt (Short + Long Term) | $671.4M | $618.7M | $761.6M |
| Total Stockholders' Equity | $5.15B | $5.17B | $1.56B |